These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17692573)

  • 41. An open-label trial of levetiracetam for treatment of cervical dystonia.
    Tarsy D; Ryan RK; Ro SI
    Mov Disord; 2006 May; 21(5):734-5. PubMed ID: 16570301
    [No Abstract]   [Full Text] [Related]  

  • 42. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
    Wheless JW; Clarke D; Hovinga CA; Ellis M; Durmeier M; McGregor A; Perkins F
    J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of levetiracetam in the management of post-anoxic myoclonias. A report of two cases].
    Lay-Son Rivas L; Pizarro Segura J; Meza Flores R
    Neurologia; 2007 Dec; 22(10):915-6. PubMed ID: 18040909
    [No Abstract]   [Full Text] [Related]  

  • 44. [Myoclonias with a propiospinal and radicular origin: their response to levetiracetam].
    Vaamonde-Gamo J; Martinez-Palomeque G; Alvarez-Soria MJ; Flores-Barragan JM; Ibanez R; Cabello-De la Rosa JP
    Rev Neurol; 2010 Jul; 51(2):126-7. PubMed ID: 20602319
    [No Abstract]   [Full Text] [Related]  

  • 45. Levetiracetam monotherapy in newly diagnosed cryptogenic West syndrome.
    Gümüş H; Kumandaş S; Per H
    Pediatr Neurol; 2007 Nov; 37(5):350-3. PubMed ID: 17950421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute levetiracetam overdose presented with mild adverse events.
    Chayasirisobhon S; Chayasirisobhon WV; Tsay CC
    Acta Neurol Taiwan; 2010 Dec; 19(4):292-5. PubMed ID: 21210332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Levetiracetam: new indication. Tonic-clonic seizures: another second-line option. No comparison with other antiepileptics.
    Prescrire Int; 2008 Apr; 17(94):59. PubMed ID: 18516810
    [No Abstract]   [Full Text] [Related]  

  • 48. Levetiracetam for the treatment of epilepsy among adults with intellectual disabilities.
    Deb S; Kaur Saini ST
    J Intellect Disabil Res; 2007 Jul; 51(Pt 7):564-5. PubMed ID: 17537170
    [No Abstract]   [Full Text] [Related]  

  • 49. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy.
    Belcastro V; Costa C; Galletti F; Rossi A; Tambasco N; Striano P
    Epilepsy Behav; 2009 Jan; 14(1):269-70. PubMed ID: 18804185
    [No Abstract]   [Full Text] [Related]  

  • 51. Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy.
    Bailey KS; Dewey CW; Boothe DM; Barone G; Kortz GD
    J Am Vet Med Assoc; 2008 Mar; 232(6):867-72. PubMed ID: 18341442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
    Verrotti A; Cerminara C; Coppola G; Franzoni E; Parisi P; Iannetti P; Aloisi P; Tozzi E; Cusmai R; Vigevano F; Chiarelli F; Curatolo P
    Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful treatment of Holmes tremor by levetiracetam.
    Ferlazzo E; Morgante F; Rizzo V; Sciarrone G; Meduri M; Magaudda A; Girlanda P; Quartarone A
    Mov Disord; 2008 Oct; 23(14):2101-3. PubMed ID: 18785235
    [No Abstract]   [Full Text] [Related]  

  • 54. The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production.
    Mintz M; Legoff D; Scornaienchi J; Brown M; Levin-Allen S; Mintz P; Smith C
    J Child Neurol; 2009 Jul; 24(7):807-15. PubMed ID: 19189934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
    Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stevens-Johnson syndrome induced by levetiracetam.
    Zou LP; Ding CH; Song ZJ; Li XF
    Seizure; 2012 Dec; 21(10):823-5. PubMed ID: 23036769
    [No Abstract]   [Full Text] [Related]  

  • 57. Recurrent severe ulcers due to seizures.
    Meyer S; Oster I; Peterlini S; Gortner L; Kutschke G
    Indian J Pediatr; 2014 Nov; 81(11):1270-1. PubMed ID: 24794326
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficacy of levetiracetam in hemifacial spasm: a case report.
    Biagio Carrieri P; Petracca M; Montella S
    Clin Neuropharmacol; 2008; 31(3):187-8. PubMed ID: 18520988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Charles Bonnet syndrome disappearing with carbamazepine and valproic acid but not with levetiracetam.
    Segers K
    Acta Neurol Belg; 2009 Mar; 109(1):42-3. PubMed ID: 19402573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Levetiracetam-induced platelet dysfunction.
    Hacquard M; Richard S; Lacour JC; Lecompte T; Vespignani H
    Epilepsy Res; 2009 Sep; 86(1):94-6. PubMed ID: 19447009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.